288 related articles for article (PubMed ID: 2856924)
41. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
42. Dehydrogenase binding by tiazofurin anabolites.
Goldstein BM; Bell JE; Marquez VE
J Med Chem; 1990 Apr; 33(4):1123-7. PubMed ID: 1969483
[TBL] [Abstract][Full Text] [Related]
43. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
[TBL] [Abstract][Full Text] [Related]
44. Determination of thiazole-4-carboxamide adenine dinucleotide (TAD) levels in mononuclear cells of leukemic patients treated with tiazofurin.
Zhen W; Jayaram HN; Weber G
Biochem Pharmacol; 1991 Jan; 41(2):281-6. PubMed ID: 1989637
[TBL] [Abstract][Full Text] [Related]
45. Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia.
Tricot GJ; Jayaram HN; Nichols CR; Pennington K; Lapis E; Weber G; Hoffman R
Cancer Res; 1987 Sep; 47(18):4988-91. PubMed ID: 3476200
[TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
Pani A; Marongiu ME; Pinna E; Scintu F; Perra G; Montis AD; Manfredini S; La Colla P
Anticancer Res; 1998; 18(4A):2623-30. PubMed ID: 9703919
[TBL] [Abstract][Full Text] [Related]
47. The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs.
Arnold ST; Jayaram HN; Harper GR; Litterst CL; Malspeis L; DeSouza JJ; Staubus AE; Ahluwalia GS; Wilson YA; Cooney DA
Drug Metab Dispos; 1984; 12(2):165-73. PubMed ID: 6144481
[TBL] [Abstract][Full Text] [Related]
48. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
49. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
[TBL] [Abstract][Full Text] [Related]
50. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
Yamada Y; Natsumeda Y; Weber G
Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors.
Franchetti P; Cappellacci L; Pasqualini M; Petrelli R; Jayaprakasan V; Jayaram HN; Boyd DB; Jain MD; Grifantini M
Bioorg Med Chem; 2005 Mar; 13(6):2045-53. PubMed ID: 15727858
[TBL] [Abstract][Full Text] [Related]
52. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase.
Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM
J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914
[TBL] [Abstract][Full Text] [Related]
53. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
[TBL] [Abstract][Full Text] [Related]
54. Antitumor activity of tiazofurin in human colon carcinoma HT-29.
Zhen W; Jayaram HN; Weber G
Cancer Invest; 1992; 10(6):505-11. PubMed ID: 1358409
[TBL] [Abstract][Full Text] [Related]
55. 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V
Bioorg Med Chem Lett; 2006 Oct; 16(20):5317-20. PubMed ID: 16908146
[TBL] [Abstract][Full Text] [Related]
56. Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
Weber G; Nagai M; Natsumeda Y; Eble JN; Jayaram HN; Paulik E; Zhen WN; Hoffman R; Tricot G
Cancer Commun; 1991 Mar; 3(3):61-6. PubMed ID: 1705812
[TBL] [Abstract][Full Text] [Related]
57. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
[TBL] [Abstract][Full Text] [Related]
58. Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.
Look KY; Sutton GP; Natsumeda Y; Eble JN; Stehman FB; Ehrlich CE; Olah E; Prajda N; Bosze P; Eckhardt S
Gynecol Oncol; 1992 Oct; 47(1):66-70. PubMed ID: 1358769
[TBL] [Abstract][Full Text] [Related]
59. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
60. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
Boritzki TJ; Berry DA; Besserer JA; Cook PD; Fry DW; Leopold WR; Jackson RC
Biochem Pharmacol; 1985 Apr; 34(7):1109-14. PubMed ID: 3985993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
